H, T., T, H., M, O., J, Y., M, K., Y, F., & D, N. (2026). High-Throughput Heterospheroid-Based Screening Identifies Drugs That Reprogram Tumor-Associated Macrophages. Journal of immunology research, 2026(1), e2889509. https://doi.org/10.1155/jimr/2889509
Chicago Style (17th ed.) CitationH, Tsuchiya, Hanaki T, Obora M, Yoshida J, Kishino M, Fujiwara Y, and Nanba D. "High-Throughput Heterospheroid-Based Screening Identifies Drugs That Reprogram Tumor-Associated Macrophages." Journal of Immunology Research 2026, no. 1 (2026): e2889509. https://doi.org/10.1155/jimr/2889509.
MLA (9th ed.) CitationH, Tsuchiya, et al. "High-Throughput Heterospheroid-Based Screening Identifies Drugs That Reprogram Tumor-Associated Macrophages." Journal of Immunology Research, vol. 2026, no. 1, 2026, p. e2889509, https://doi.org/10.1155/jimr/2889509.